Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 52

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Association of High-Level Mupirocin Resistance and Multidrug-Resistant Methicillin-Resistant Staphylococcus aureus at an Academic Center in the Midwestern United States

Cadilla, Adriana, David, Michael Z., Daum, Robert S., Boyle-Vavra, Susan·2011·Journal of Clinical Microbiology

Abstract

Mupirocin is a topical antimicrobial used to eradicate methicillin-resistant Staphylococcus aureus (MRSA) colonization, usually in the absence of susceptibility testing. We hypothesized that high-level (HL) mupirocin resistance was associated with multidrug resistance (MDR). To this end, unique patient isolates identified at our institution during 2008 were stratified into those resistant to ≥3 non-β-lactam antimicrobial classes (MDR) and non-MDR MRSA. HL mupirocin resistance was screened by mupA PCR on all MDR isolates ( n = 191) and a 20% random sample ( n = 130) of non-MDR isolates; E-testing confirmed HL resistance. We found that among MDR isolates, 13 (6.8%) carried mupA , whereas none of the non-MDR isolates did ( P = 0.001). Thus, although the overall prevalence of HL mupirocin resistance is low among MRSA isolates at our institution, an association exists between mupA carriage and MDR. Using genotyping and antimicrobial susceptibility profiling, we identified nine HL mupirocin-resistant clones. Whereas the majority of mupA -negative MDR isolates had a health care-associated MRSA (HA-MRSA) genotype (multilocus sequence type 5 [ST5] or SCC mec type II), the majority of mupA -positive MDR isolates had a community-associated MRSA (CA-MRSA) genotype (ST8 or SCC mec type IV). However, CA- and HA-MRSA genotypes were more evenly distributed among mupA -positive isolates compared to mupA -negative MDR isolates. Thus, in Chicago, mupA is circulating among both CA- and HA-MRSA backgrounds.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jcm.00759-10

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 32

  1. Aubry-Damon H. C. J. Soussy and P. Courvalin. 1998. Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus . Antimicrob. Agents Chemother. 42 : 2590-2594. · DOI · Paper page
  2. Babu T. V. Rekasius J. P. Parada P. Schreckenberger and M. Challapalli. 2009. Mupirocin resistance among methicillin-resistant Staphylococcus aureus -colonized patients at admission to a tertiary care medical center. J. Clin. Microbiol. 47 : 2279-2280. · DOI
  3. Bischoff W. E. M. L. Wallis K. B. Tucker B. A. Reboussin and R. J. Sherertz. 2004. Staphylococcus aureus nasal carriage in a student community: prevalence clonal relationships and risk factors. Infect. Control Hosp. Epidemiol. 25 : 485-491. · DOI
  4. Bowler W. A. J. Bresnahan A. Bradfish and C. Fernandez. 2010. An integrated approach to methicillin-resistant Staphylococcus aureus control in a rural regional-referral healthcare setting. Infect. Control Hosp. Epidemiol. 31 : 269-275. · DOI
  5. Boyle-Vavra S. and R. S. Daum. 2007. Community-acquired methicillin-resistant Staphylococcus aureus : the role of Panton-Valentine leukocidin. Lab. Invest. 87 : 3-9. · DOI · Paper page
  6. Boyle-Vavra S. B. Ereshefsky C. C. Wang and R. S. Daum. 2005. Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei Taiwan that carries either the novel Staphylococcal chromosome cassette mec (SCC mec ) type VT or SCC mec type IV. J. Clin. Microbiol. 43 : 4719-4730. · DOI · Paper page
  7. Cadilla A. R. S. Daum and S. Boyle-Vavra. 2009. Mupirocin resistance associated with multi-drug resistant MRSA. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. abstr. C2-140.
  8. David M. Z. D. Glikman S. E. Crawford J. Peng K. J. King M. A. Hostetler S. Boyle-Vavra and R. S. Daum. 2008. What is community-associated methicillin-resistant Staphylococcus aureus ? J. Infect. Dis. 197 : 1235-1243. · DOI · Paper page
  9. Deshpande L. M. A. M. Fix M. A. Pfaller and R. N. Jones. 2002. Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion Etest and reference dilution methods. Diagn. Microbiol. Infect. Dis. 42 : 283-290. · DOI
  10. Diep B. A. H. F. Chambers C. J. Graber J. D. Szumowski L. G. Miller L. L. Han J. H. Chen F. Lin J. Lin T. H. Phan H. A. Carleton L. K. McDougal F. C. Tenover D. E. Cohen K. H. Mayer G. F. Sensabaugh and F. Perdreau-Remington. 2008. Emergence of multidrug-resistant community-associated methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann. Intern. Med. 148 : 249-257. · DOI · Paper page
  11. Eltringham I. 1997. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA). J. Hosp. Infect. 35 : 1-8. · doi:10.1016/s0195-6701(97)90162-6
  12. Enright M. C. N. P. Day C. E. Davies S. J. Peacock and B. G. Spratt. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus . J. Clin. Microbiol. 38 : 1008-1015. · DOI · Paper page
  13. Farmer T. H. J. Gilbart and S. W. Elson. 1992. Biochemical basis of mupirocin resistance in strains of Staphylococcus aureus . J. Antimicrob. Chemother. 30 : 587-596. · doi:10.1093/jac/30.5.587
  14. Han L. L. L. K. McDougal R. J. Gorwitz K. H. Mayer J. B. Patel J. M. Sennott and J. L. Fontana. 2007. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center. J. Clin. Microbiol. 45 : 1350-1352. · DOI
  15. Herold B. C. L. C. Immergluck M. C. Maranan D. S. Lauderdale R. E. Gaskin S. Boyle-Vavra C. D. Leitch and R. S. Daum. 1998. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279 : 593-598. · DOI · Paper page
  16. Ito T. Y. Katayama K. Asada N. Mori K. Tsutsumimoto C. Tiensasitorn and K. Hiramatsu. 2001. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus . Antimicrob. Agents Chemother. 45 : 1323-1336. · DOI · Paper page
  17. Jones J. C. T. J. Rogers P. Brookmeyer W. M. Dunne Jr. G. A. Storch C. M. Coopersmith V. J. Fraser and D. K. Warren. 2007. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin. Infect. Dis. 45 : 541-547. · DOI
  18. Jones P. G. T. Sura M. Harris and A. Strother. 2003. Mupirocin resistance in clinical isolates of Staphylococcus aureus . Infect. Control Hosp. Epidemiol. 24 : 300-301. · doi:10.1086/502204
  19. Koreen L. S. V. Ramaswamy E. A. Graviss S. Naidich J. M. Musser and B. N. Kreiswirth. 2004. spa typing method for discriminating among Staphylococcus aureus isolates : implications for use of a single marker to detect genetic micro- and macrovariation. J. Clin. Microbiol. 42 : 792-799. · DOI · Paper page
  20. LaPlante K. L. 2007. In vitro activity of lysostaphin mupirocin and tea tree oil against clinical methicillin-resistant Staphylococcus aureus . Diagn. Microbiol. Infect. Dis. 57 : 413-418. · DOI
  21. McDougal L. K. G. E. Fosheim A. Nicholson S. N. Bulens B. M. Limbago J. E. Shearer A. O. Summers and J. B. Patel. 2010. Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States. Antimicrob. Agents Chemother. 54 : 3804-3811. · DOI · Paper page
  22. Mongkolrattanothai K. P. Mankin V. Raju and B. Gray. 2008. Surveillance for mupirocin resistance among methicillin-resistant Staphylococcus aureus clinical isolates. Infect. Control Hosp. Epidemiol. 29 : 993-994. · doi:10.1086/590536
  23. O'Shea S. L. Cotter S. Creagh S. Lydon and B. Lucey. 2009. Mupirocin resistance among staphylococci: trends in the southern region of Ireland. J. Antimicrob. Chemother. 64 : 649-650. · doi:10.1093/jac/dkp227
  24. Patel J. B. R. J. Gorwitz and J. A. Jernigan. 2009. Mupirocin resistance. Clin. Infect. Dis. 49 : 935-941. · DOI · Paper page
  25. Paterson D. L. J. D. Rihs C. Squier T. Gayowski A. Sagnimeni and N. Singh. 2003. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates. Transplantation 75 : 194-198. · DOI
  26. Perl T. M. J. J. Cullen R. P. Wenzel M. B. Zimmerman M. A. Pfaller D. Sheppard J. Twombley P. P. French and L. A. Herwaldt. 2002. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N. Engl. J. Med. 346 : 1871-1877. · DOI · Paper page
  27. Ridenour G. R. Lampen J. Federspiel S. Kritchevsky E. Wong and M. Climo. 2007. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect. Control Hosp. Epidemiol. 28 : 1155-1161. · DOI
  28. Rotger M. A. Trampuz K. E. Piper J. M. Steckelberg and R. Patel. 2005. Phenotypic and genotypic mupirocin resistance among staphylococci causing prosthetic joint infection. J. Clin. Microbiol. 43 : 4266-4268. · doi:10.1128/jcm.43.8.4266-4268.2005
  29. Simor A. E. T. L. Stuart L. Louie C. Watt M. Ofner-Agostini D. Gravel M. Mulvey M. Loeb A. McGeer E. Bryce and A. Matlow. 2007. Mupirocin-resistant methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob. Agents Chemother. 51 : 3880-3886. · DOI · Paper page
  30. Udo E. E. L. E. Jacob and B. Mathew. 2001. Genetic analysis of methicillin-resistant Staphylococcus aureus expressing high- and low-level mupirocin resistance. J. Med. Microbiol. 50 : 909-915. · doi:10.1099/0022-1317-50-10-909
  31. Vasquez J. E. E. S. Walker B. W. Franzus B. K. Overbay D. R. Reagan and F. A. Sarubbi. 2000. The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital. Infect. Control Hosp. Epidemiol. 21 : 459-464. · doi:10.1086/501788
  32. Wikler M. A. 2008. Performance standards for antimicrobial susceptibility testing: 18th informational supplement vol. 28. Clinical and Laboratory Standards Institute Wayne PA.

Cited by

See all 52

Metadata

Authors
Cadilla, A., David, M. Z., Daum, R. S., & Boyle-Vavra, S.
Affiliations
Infectious Diseases Section, Department of Pediatrics, The University of Chicago, Chicago, Illinois
Venue
Journal of Clinical Microbiology
Published
2011-01
Volume
49
Issue
1
Pages
95-100
ISSN
  • 0095-1137
  • 1098-660X
Cited by
52
References
3
Language
en
Licence
journals.asm.org/non-commercial-tdm-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of High-Level Mupirocin Resistance and Multidrug-Resistant Methicillin-Resistant Staphylococcus aureus at an Academic Center in the Midwestern United States. https://app.cochat.ai/papers/10.1128/jcm.00759-10
The paper
Cadilla, A., David, M. Z., Daum, R. S., & Boyle-Vavra, S. (2011). Association of High-Level Mupirocin Resistance and Multidrug-Resistant Methicillin-Resistant Staphylococcus aureus at an Academic Center in the Midwestern United States. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00759-10

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.